Track topics on Twitter Track topics that are important to you
Shanghai Fosun Pharma paid $36 million to buy an older GlaxoSmithKline drug making facility in Suzhou, along with non-exclusive rights to manufacture lamivudine, a GSK treatment for hepatitis B/HIV. Last week, GSK officially opened a new $95 million Singapore facility that uses an enzyme-based continuous manufacturing process. The process is less expensive and more friendly to the environment than traditional chemical synthesis. Initially, GSK's new facility will produce Daprodustat, an oral treatment for anemia associated with chronic kidney disease. More details....
Stock Symbols: (SHA: 600196; HK: 2196) (NYSE: GSK)
Share this with colleagues:
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...